Steven D Culler1, David S Jevsevar2, Kevin J McGuire3, Kevin G Shea4, Kenneth M Little5, Michael J Schlosser6. 1. Rollins School of Public Health, Emory University, Atlanta, Georgia. 2. Department of Orthopaedics, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. 3. Beth Israel Deaconess Medical Center, Boston, Massachusetts. 4. St Luke's Health System, Boise, Idaho; Department of Orthopedics, University of Utah, Salt Lake, Utah. 5. St Luke's Health System, Boise, Idaho. 6. Clinical Data Solutions, A Division of HealthTrust Purchasing Group, LLP, Nashville, Tennessee.
Abstract
BACKGROUND: The Medicare program's Comprehensive Care for Joint Replacement (CJR) payment model places hospitals at financial risk for the treatment cost of Medicare beneficiaries (MBs) undergoing lower extremity joint replacement (LEJR). METHODS: This study uses Medicare Provider Analysis and Review File and identified 674,777 MBs with LEJR procedure during fiscal year 2014. Adverse events (death, acute myocardial infarction, pneumonia, sepsis or shock, surgical site bleeding, pulmonary embolism, mechanical complications, and periprosthetic joint infection) were studied. Multivariable regressions were modeled to estimate the incremental hospital cost of treating each adverse event. RESULTS: The risk-adjusted estimated hospital cost of treating adverse events varied from a high of $29,061 (MBs experiencing hip fracture and joint infection) to a low of $6308 (MBs without hip fracture that experienced pulmonary embolism). CONCLUSION: Avoidance of adverse events in the LEJR hospitalization will play an important role in managing episode hospital costs in the Comprehensive Care for Joint Replacement program.
BACKGROUND: The Medicare program's Comprehensive Care for Joint Replacement (CJR) payment model places hospitals at financial risk for the treatment cost of Medicare beneficiaries (MBs) undergoing lower extremity joint replacement (LEJR). METHODS: This study uses Medicare Provider Analysis and Review File and identified 674,777 MBs with LEJR procedure during fiscal year 2014. Adverse events (death, acute myocardial infarction, pneumonia, sepsis or shock, surgical site bleeding, pulmonary embolism, mechanical complications, and periprosthetic joint infection) were studied. Multivariable regressions were modeled to estimate the incremental hospital cost of treating each adverse event. RESULTS: The risk-adjusted estimated hospital cost of treating adverse events varied from a high of $29,061 (MBs experiencing hip fracture and joint infection) to a low of $6308 (MBs without hip fracture that experienced pulmonary embolism). CONCLUSION: Avoidance of adverse events in the LEJR hospitalization will play an important role in managing episode hospital costs in the Comprehensive Care for Joint Replacement program.
Authors: Benjamin F Ricciardi; Andrew Y Liu; Bowen Qiu; Thomas G Myers; Caroline P Thirukumaran Journal: Clin Orthop Relat Res Date: 2019-05 Impact factor: 4.176
Authors: Jie J Yao; Mario Hevesi; Sue L Visscher; Jeanine E Ransom; David G Lewallen; Daniel J Berry; Hilal Maradit Kremers Journal: J Bone Joint Surg Am Date: 2021-02-17 Impact factor: 5.284